XML 17 R4.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Statements of Operations - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Revenues $ 22,550 $ 30,467
Costs and expenses:    
Cost of sales 11,912 19,637
Selling, general and administrative 13,600 17,191
Restructuring charge 625
Research and development 1,177 1,127
Intangible assets abandonment and impairment 197 127
Total Costs and Expenses 26,886 38,707
Operating loss from continuing operations (4,336) (8,240)
Interest (expense) (4)  
Interest income   41
Foreign exchange gain 370
Other income (loss) 119 (8)
Loss from continuing operations before income taxes (4,221) (7,837)
Income tax expense (57) (14)
Net loss from continuing operations (4,278) (7,851)
Loss from discontinued operations (net of income tax benefit of $0 in 2020 and 2019) (1)
Net loss $ (4,278) $ (7,852)
Net loss per common share:    
Continuing operations (in dollars per share) $ (0.17) $ (0.32)
Discontinued operations (in dollars per share) 0
Basic net loss per common share (in dollars per share) (0.17) (0.32)
Diluted    
Continuing operations (in dollars per share) (0.17) (0.32)
Discontinued operations (in dollars per share)
Diluted net loss per common share (in dollars per share) $ (0.17) $ (0.32)
Weighted-average number of common shares outstanding:    
Basic weighted-average shares (in shares) 24,691,000 24,202,000
Diluted (in shares) 24,691,000 24,202,000